CLEVIPREX J Code: J0759
Injection, clevidipine butyrate, 1 mg
Drug & Product Overview
About CLEVIPREX
Cleviprex is a medication aligned to the HCPCS J Code: J0759 for billing, pricing, and reimbursement purposes in the United States. This Cardiology medication is administered via the intravenous route and manufactured by Chiesi USA.
According to CMS Drug Use Information: Drug uses not available
Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.
NDC Code Information
Based on publicly available CMS files. Showing 2 of 4 NDCs — log in for the full crosswalk.
| NDC Code | Drug | Manufacturer | Billing Units / Pkg | Package Size |
|---|---|---|---|---|
| 10122-0610-10 | Cleviprex | Chiesi USA, Inc. | 250 | 25 MG / 50 ML |
| 10122-0611-10 | Cleviprex | Chiesi USA, Inc. | 500 | 50 MG / 100 ML |
| •••••-••••-•• Log in to view | CLEVIPREX | •••••••••••• Log in to view | •••• Log in to view | ••• •• / • •• Log in to view |
| •••••-••••-•• Log in to view | CLEVIPREX | •••••••••••• Log in to view | •••• Log in to view | ••• •• / • •• Log in to view |
CLEVIPREX Pricing & Reimbursement
National median reimbursement across major commercial payers.
Create an account on PayerPrice for more information →Historical Graphing and Billing Calculator
Log in to calculate billing and reimbursement with live ASP, WAC & AWP pricing.
Login to use the calculator →Clevidipine Butyrate 505(b)(2) Information:
| HCPCS Code | Manufacturer | Active Ingredient | HCPCS Description |
|---|---|---|---|
| J0759 | Chiesi USA | Clevidipine Butyrate | Injection, clevidipine butyrate, 1 mg |
CLEVIPREX CPT Administration Codes
The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.
| CPT Code | Description |
|---|---|
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure) |
This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →
CLEVIPREX Medically Unlikely Edits (MUE)
The most billing units of J0759 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 1 mg.
MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →
CLEVIPREX Clinical Information
Indications and drug classification.
This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.
Login for BuyandBill.com Analytics
Unlock deeper insights with BuyandBill’s Comparative Report!
- Compare ASP, WAC, and AWP across drugs.
- Visualize Drug Price Movement Over Time
- Tailor reports to drug class, manufacturer, or HCPCS Code.
- Compare Biosimilar and 505(b)(2) products.
Frequently Asked Questions
Is there an available Cleviprex billing and coding guide?
Are there any available Cleviprex patient assistance programs?
Where can I find Cleviprex prescribing information?
Where can I find Cleviprex side effect information?
Does billing Cleviprex require wastage modifiers?
About BuyandBill.com:
The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.
Related Drug Codes
Explore billing, coding, and pricing for drugs related to CLEVIPREX.